-
Mashup Score: 19Publishing excellence with The Lancet Planetary Health - 4 day(s) ago
Thursday, June 27, 2024 at 4:00 PM British Summer Time.
Source: event.on24.comCategories: General Medicine News, General Journals & SocietTweet
-
Mashup Score: 52Theranostics in Oncology - 4 day(s) ago
The clinical use of diagnostic and therapeutic radiopharmaceuticals—theranostics—in oncology has expanded rapidly over the past decade with regulatory approval for therapeutic use in neuroendocrine tumours and prostate cancer. In the first paper in this four-part Series, Suzanne Lapi and colleagues summarise the current landscape of radiopharmaceutical sciences in oncology including progress in radiochemistry and the production of radionuclides, the development and use of theranostics, and the application
Source: www.thelancet.comCategories: General Medicine News, General Journals & SocietTweet
-
Mashup Score: 53Antimicrobial Resistance: a silent pandemic - 4 day(s) ago
Members of the WHO Task Force of AMR Survivors share their personal experiences with Antimicrobial Resistance.Featuring in this video are Tori Kinamon, Bhakt…
Source: www.youtube.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 5The Lancet Series on Antimicrobial Resistance: The need for sustainable access to effective antibiotics - 4 day(s) ago
Access to effective antibiotics is essential to every health system in the world, however, antimicrobial resistance (AMR) threatens this backbone of modern medicine and is already leading to deaths and disease which would have once been prevented. This Series highlights that, although AMR can affect anyone throughout the life course, the very young, very old and severely ill are the ones suffering the most. Through novel modelling data, this Series shows how stopping infections through improved vaccination
Source: www.thelancet.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 7
Thank you for your interest. Please find more information about the journal and our Youth Advisory Panel below, and use the form on the next page to get in touch by 31st May, 2024. If you have any questions, please feel free to email child-adolescent@lancet.com.Â
Source: forms.office.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 11Sex, race, and BMI in clinical trials of medications for obesity over the past three decades: a systematic review - 5 day(s) ago
Medications for obesity have been studied in various populations over the past three decades. We aimed to quantify the baseline demographic characteristics of BMI, sex, age, and race in randomised clinical trials (RCTs) across three decades to establish whether the population studied is representative of the global population affected by the disease. Clinical trials of 12 medications for obesity (ie, orlistat, naltrexone–bupropion, topiramate–phentermine, liraglutide, semaglutide, lorcaserin, sibutramine, rimonabant, taranabant, tirzepatide, retatrutide, and orforglipron) published from Jan 20, 1999, to Nov 12, 2023, were assessed through a systematic review for methodological quality and baseline demographic characteristics.
Source: www.thelancet.comCategories: General Medicine News, General Journals & SocietTweet
-
Mashup Score: 27Why not eliminate HTLV-1 while eliminating HIV-1? - 5 day(s) ago
In 2018, we asked WHO to adopt the sexually transmitted oncovirus, human T-cell leukaemia virus 1 (HTLV-1) as a threat to human health.1 Consequently, WHO announced that HTLV-1’s elimination is targeted in their Global Health Sector Strategies on HIV, viral hepatitis, and sexually transmitted infections by 2030.2 WHO also assigned a new International Classification of Diseases-11 code to HTLV-1 associated myelopathy. In 2024, the Pan American Health Organization included HTLV-1 in the mother-to-child HIV, syphilis, hepatitis B and C, chagas (EMTCT Plus) elimination protocol.
Source: www.thelancet.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 37
Join us on May 28
Source: www.eventcreate.comCategories: General Medicine News, General Journals & SocietTweet
-
Mashup Score: 203Systemic lupus erythematosus - 6 day(s) ago
Systemic lupus erythematosus (SLE) is a multisystemic autoimmune disease characterised by the presence of autoantibodies towards nuclear antigens, immune complex deposition, and chronic inflammation at classic target organs such as skin, joints, and kidneys. Despite substantial advances in the diagnosis and management of SLE, the burden of disease remains high. It is important to appreciate the typical presentations and the diagnostic process to facilitate early referral and diagnosis for patients.
Source: www.thelancet.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 36Chronic suppurative otitis media - 7 day(s) ago
Chronic suppurative otitis media (CSOM) is a leading global cause of potentially preventable hearing loss in children and adults, associated with socioeconomic deprivation. There is an absence of consensus on the definition of CSOM, which complicates efforts for prevention, treatment, and monitoring. CSOM occurs when perforation of the tympanic membrane is associated with severe or persistent inflammation in the middle ear, leading to hearing loss and recurrent or persistent ear discharge (otorrhoea).
Source: www.thelancet.comCategories: General Medicine News, General HCPsTweet
đź“ŁUpcoming webinarđź“Ł Join the editors of The Lancet Planetary Health for a webinar discussing the journal's aims, what they look for in research papers, and how to prepare your manuscript for publication. Register now: https://t.co/K0OvxA7e8y https://t.co/u7t5T5nNld